secwatch.observer — SEC 8-K summary
======================================

Issuer:     Health Catalyst, Inc. (HCAT)
CIK:        0001636422
Form:       8-K
Filed at:   2023-10-27T23:59:59+00:00
Accession:  0001636422-23-000124
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Health Catalyst beats Q3 rev midpoint; raises FY rev guidance; Adj. EBITDA positive
--------------------------------------------------------------------------------

- Total revenue $73.8M (+8% YoY); tech revenue $46.0M (+4%), pro services $27.8M (+14%).
- Net loss $22.0M vs $45.7M loss YoY (improved 52%); loss from ops $24.6M vs $45.7M.
- Adjusted EBITDA $2.0M vs ($4.6M) loss a year ago; Q3 beat midpoint on both rev and EBITDA.
- Raised FY2023 revenue guidance range; reiterated FY2023 Adjusted EBITDA guidance.
- Full Q3 results and conference call rescheduled to November 2, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636422/000163642223000124/0001636422-23-000124-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636422/000163642223000124/hcat-20231027.htm
  HTML page:      https://secwatch.observer/filing/0001636422-23-000124

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer